Glaxosmithkline Intellectual Property (No.3) Limited

Calculating rank

USPTO Granted Patents = 3

Forward Citations = 0

Loading Chart...

7 inventors (with patents filed for the assignee):

Nathalie Chauret (3 out of 4 patents)

Jeremy Green (2 out of 62 patents)

Karine Villeneuve (2 out of 2 patents)

4. Denis Garceau (1 out of 3 patents)

5. David R Kronenthal (1 out of 40 patents)

6. Robert M Wenslow, Jr (1 out of 1 patent)

7. Kemal Payza (1 out of 1 patent)

3 patents: Sort by Forward Citations

1. 12655145 - P2X3 modulators (2026-06-16),

2. 12637452 - Crystalline forms of a substituted imidazopyridine compound and use thereof as P2X3 modulator (2026-05-26),

3. 12503470 - Preparation of a P2X3 antagonist (2025-12-23),

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

3 Patents

#14 in Stevenage

#4,895 in United Kingdom

Stevenage, United Kingdom

Glaxosmithkline Intellectual Property (No.3) Limited

Forward Citations = 0

7 inventors:

Nathalie Chauret (3 out of 4 patents)

Jeremy Green (2 out of 62 patents)

Karine Villeneuve (2 out of 2 patents)

4. Denis Garceau (1 out of 3 patents)

5. David R Kronenthal (1 out of 40 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Glaxosmithkline Intellectual Property (No.3) Limited. Retrieved from https://idiyas.com/company/glaxosmithkline-intellectual-property-no3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]